Maxcyte, Inc. (MXCT)

CIK 1287098 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Maxcyte, Inc..

Recent SEC filings

FiledFormAccession number
Aug 13, 202610-Q0001104659-26-095971
Aug 12, 20268-K0001104659-26-094886
Aug 4, 2026SCHEDULE 13D0001486180-26-000003
Jul 29, 2026SCHEDULE 13G/A0002012383-26-002825
Jun 22, 202640000905148-26-003056
Jun 22, 202640000905148-26-003054
Jun 22, 202640000905148-26-003052
Jun 22, 202640000905148-26-003050
Jun 22, 202640000905148-26-003055
Jun 22, 202640000905148-26-003053
Jun 22, 202640000905148-26-003049
Jun 22, 202640000905148-26-003051
Jun 17, 20268-K0001104659-26-075211
Jun 16, 20268-K0001104659-26-074594
May 14, 2026SCHEDULE 13D0001486180-26-000002
May 13, 202610-Q0001104659-26-060290
May 12, 20268-K0001104659-26-059399
Apr 29, 2026DEFA14A0001140361-26-017845
Apr 29, 2026DEF 14A0001140361-26-017844
Apr 29, 2026ARS0001140361-26-017847
Apr 17, 202640000905148-26-001718
Apr 15, 2026S-80001104659-26-043814
Apr 10, 2026SCHEDULE 13G/A0001172661-26-001441
Apr 10, 202630000905148-26-001643
Apr 10, 202640000905148-26-001644